Trueblue, INC
Market Movers (8-K)
NYSE
TrueBlue, Inc. has amended its Rights Agreement, changing the final expiration date of its Rights from May 13, 2026, to May 6, 2026.
NYSE
TrueBlue announced its first quarter 2026 financial results, reporting an 8% increase in revenue to $399 million, driven by growth in skilled verticals and stabilizing demand.
NYSE
TrueBlue, Inc. has entered into a cooperation agreement with EHS Investments, leading to the appointment of a new independent director and the withdrawal of EHS's prior nominations.
NYSE
TrueBlue, Inc. has amended its credit agreement, converting its revolving credit facility to an asset-based lending structure and reducing its line of credit from $255 million to $175 million.
Worse than expected
NYSE
TrueBlue, Inc. announced the appointment of Brian Capone as Senior Vice President and Chief Accounting Officer, effective January 12, 2026.
NYSE
TrueBlue, Inc. issued a statement responding to EHS Management's director nominations, emphasizing recent board changes and strategic initiatives for profitable growth.
Worse than expected
Quarterly Earnings (10-Q)
NYSE
TrueBlue, Inc. announced its first-quarter 2026 results, showing a 7.6% increase in revenue to $398.6 million, but a wider net loss of $19.8 million compared to $14.3 million in the prior year.
Worse than expected
NYSE
TrueBlue, Inc. reports a 12.8% revenue increase in Q3 2025, narrowing its net loss, driven by skilled businesses and the HSP acquisition, despite margin pressures.
Capital raise
NYSE
TrueBlue, Inc. reported a significant reduction in net loss for the second quarter of 2025, driven by lower impairment charges and cost management, despite flat revenue and declining gross profit margins.
Better than expected
Capital raise
NYSE
10-Q: TrueBlue Reports Q1 2025 Results: Revenue Declines Amidst Soft Demand, Acquisition Provides Boost
TrueBlue's Q1 2025 revenue decreased by 8.1% year-over-year due to soft demand for temporary labor and permanent hiring, though the acquisition of Healthcare Staffing Professionals (HSP) provided some offset.
Worse than expected
NYSE
TrueBlue Inc. experienced a significant revenue decline in Q3 2024, leading to a net loss and a substantial goodwill impairment charge, reflecting ongoing economic uncertainty and reduced client demand.
Worse than expected
NYSE
TrueBlue Inc. reported a substantial net loss for the second quarter of 2024, primarily due to a significant goodwill impairment charge and a challenging economic environment.
Worse than expected
Annual Reports (10-K)
NYSE
TrueBlue, Inc. reports a significant net loss for fiscal year 2024, driven by declining revenue, impairment charges, and increased tax expenses amid ongoing economic uncertainty.
Worse than expected
NYSE
TrueBlue, Inc.'s 10-K filing details its share structure, business segments, and financial performance for the fiscal year ended December 31, 2023, revealing a net loss amidst economic uncertainty.
Worse than expected
Insider Trading (Form 4)
NYSE
Form 4: Director Sells TrueBlue Shares
TrueBlue, Inc. Director Sonita Lontoh reported a sale of 2,186 shares of common stock on June 5, 2026, for an average price of $6.73 per share.
NYSE
Richard P. Betori of TrueBlue, Inc. reported transactions involving common stock on April 3, 2026.
NYSE
TrueBlue, Inc. CEO and President Taryn R. Owen acquired 20,400 shares of common stock, signaling strong insider confidence.
Better than expected
NYSE
TrueBlue's EVP and Chief Legal Officer, Garrett Ferencz, acquired 7,000 shares of common stock at $3.61 per share, increasing his beneficial ownership.
Better than expected
NYSE
TrueBlue, Inc. CEO and President Taryn Owen reported a disposition of 13,450 common shares to satisfy tax obligations related to equity vesting.
NYSE
TrueBlue's EVP and CFO, Carl Schweihs, reported a disposition of 3,315 common shares for tax purposes, retaining significant beneficial ownership.
Proxy Statements (Def-14A)
NYSE
TrueBlue, Inc. has announced its 2026 Annual Meeting of Shareholders, set for May 11, 2026, to vote on director elections, executive compensation, and equity plans.
NYSE
TrueBlue, Inc. sent an email to employees addressing a public letter from investor EHS Management, reaffirming its strategic plan and recent Board additions.
NYSE
TrueBlue, Inc. issued a statement defending its strategic plan and recent board changes against director nominations from EHS Management, LLC ahead of its 2026 annual meeting.
Better than expected
NYSE
TrueBlue, Inc. announced the appointment of William Greenblatt and William Seward to its Board of Directors, effective January 5, 2026, following an extensive search and shareholder input.
NYSE
TrueBlue, Inc. has filed a definitive proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.
NYSE
TrueBlue, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on May 14, 2025, featuring proposals on director elections, executive compensation, and amendments to the company's 2016 Omnibus Incentive Plan.
Worse than expected
Schedule 13G - Passive Investments
NYSE
Boston Partners has disclosed beneficial ownership of 2,470,948 shares, representing 8.13% of TrueBlue, Inc.'s common stock as of June 30, 2026.
NYSE
Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 9.18% of TrueBlue, Inc. common stock as of June 30, 2026.
NYSE
Investment adviser Boston Partners has reported a 10.83% beneficial ownership stake in TrueBlue, Inc. as of March 31, 2026.
NYSE
Invesco Ltd. has filed a Schedule 13G disclosing a 0.2% beneficial ownership stake in TrueBlue Inc. as of March 31, 2026.
NYSE
Pzena Investment Management LLC has increased its beneficial ownership of TrueBlue, Inc. common stock to 10.5%, holding over 3.17 million shares.
NYSE
Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 7.03% of TrueBlue, Inc. common stock as of March 31, 2026.